Levetiracetam Tablet, Film Coated
Product Images NDC 68180-113

This text provides a formula for calculating the total daily dose of a medication, based on the patient's weight and the daily dose prescribed in milligrams per kilogram. The medication appears to be in a liquid form with a concentration of 100 milligrams per milliliter.*

This text contains a formula for estimating renal clearance (CLer) in patients. The formula varies for male and female patients based on their weight and age. For female patients, CLer is computed using (140-age) x weight (kg) divided by 72 x serum creatinine (mg/dL). After which, the result is adjusted to account for the patient's Body Surface Area (BSA). For males, the same formula is used but with an additional constant factor of 1.23.*

This appears to be a table showing the percentages of patients in different groups receiving different dosages of levetiracetam or a placebo. However, without further context, it is difficult to determine the purpose or results of this table.*

This is a summary of a clinical trial or study that included a placebo group (51 patients) and a group treated with levetiracetam (58 patients). The percentage of patients who experienced a certain outcome is provided for each group, but the nature of the outcome is not specified.*

This appears to be a chart showing the percentage of patients experiencing a certain outcome while taking either a placebo or Levetiracetam. The chart shows the percentage of patients on a vertical scale ranging from 0% to 100%, with intervals of 10%. The horizontal axis shows the two treatment groups, Placebo (N=84) and Levetiracetam (N=79), with the percentages of patients in each group experiencing the outcome represented as bars. However, there is not enough information to determine what the outcome being measured is.*

Levetiracetam Tablets USP with NDC number 68180-112-02, is a prescription medication dispensed by pharmacists in a tightly sealed and light-resistant container with child-resistant closure. Each film-coated tablet contains levetiracetam USP 250 mg with usual dosage as outlined in the package insert for complete dosage recommendations. pharmacy dispenses it to patients with a medication guide. The medication should be stored at an average temperature of 25°C (77°F) and can be kept at excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Lupin Pharmaceuticals, Inc in Baltimore, Maryland 21202 is the company that produces LUPIN 500 Tablets. Med guide is available on www.lupin.com/levetiracetamtab- or can be seen by scanning the QR code.*

This is a description of a medication called Levetiracetam packaged by pharmaceutical company Lupin. The tablets come in 1000mg strength and are dispensed with a Medication Guide to each patient. The Pharmacist should store it in a tight light-resistant container with child-resistant closure. Complete dosage recommendations can be found in the package insert. The medication should be stored at 25°C (77°F) and excursions up to 15-30°C. The Medication Guide can be found on the Lupin website or by scanning the QR code. The manufacturer is Lupin Limited in Nagpur, India.*